Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Lincoln Tech Campus President Appointed to Maryland State Workforce Development Board
-
Fluent Secures Top Spot as the #1 Digital Agency in Ad Age's 2024 Best Places to Work List
-
Hanmi Financial Declares Cash Dividend of $0.25 per share
-
Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 Doses
-
Clean Energy Technologies Continues Normal Operations Among Stock Volatility
-
Intelligent Bio Solutions Inc. Announces Reverse Stock Split
-
ESGEN Acquisition Corp. Announces Updated Transaction Terms for its Pending Business Combination with Sunergy Renewables
-
Navitas and SHINRY Accelerate New-Energy Vehicle Developments with Next-Gen Power Semiconductors
-
NightHawk’s Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical Program
-
Roper Technologies to acquire Procare Solutions
-
BCB Bancorp, Inc. Earns $6.1 Million in Fourth Quarter 2023; Reports $0.35 EPS and Declares Quarterly Cash Dividend of $0.16 Per Share
-
Agri Supply Chooses Bridgeline’s AI-Powered Smart Search
-
Fluent Secures Top Spot as the #1 Digital Agency in Ad Age's 2024 Best Places to Work List
-
Enovis Introduces the DonJoy ROAM™ OA Knee Brace
-
AMMO, Inc. to Conduct Fiscal Third Quarter 2024 Earnings Call on February 8, 2024, at 5:00PM ET
-
Veterans’ Income, VA Disability Ratings Spotlighted In Federal Study, Allsup Reports
-
SCUDERIA FERRARI AND CHARLES LECLERC MOVING FORWARD TOGETHER
-
Form 8.3 - LXI REIT PLC
-
Form 8.3 - ABRDN European Logistics Income PLC
-
Joining Forces for School Climate Action: CFT's Sponsorship of the Inaugural Unconference
-
NobleAI Recognized as one of the Ten Hottest AI Startups to Watch in 2024
-
Form 8.3 - Equals Group PLC
-
Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis Congress
-
StepStone Group to Announce Third Quarter Fiscal 2024 Results on February 8, 2024
-
Lightspeed Commerce Announces Table Side; Roster of New Product Innovations Designed to Increase Customer Efficiency and Cost Effectiveness
-
CAE Adds Nakia Towns and Ingmar Berg to Its Board of Directors
-
CAE Adds Nakia Towns and Ingmar Berg to Its Board of Directors
-
EXL Schedules Fourth Quarter 2023 and Full Year Financial Results Conference Call
-
Woodward Increases Quarterly Dividend by 14 Percent and Authorizes $600 million Stock Repurchase Program
-
Carpenter Technology Reports Second Quarter Fiscal Year 2024 Results
-
First Merchants Corporation Announces Fourth Quarter 2023 Earnings Per Share
-
Lakeland Bancorp Announces Quarterly and Year-End 2023 Earnings
-
Falco Announces Election of Directors and Closing of Its Senior Debt Transactions
-
Azincourt Energy to Drill Test Clay Alteration at the East Preston Uranium Project
-
Aspira Women’s Health Announces $5.5 Million Registered Direct Offering and Concurrent Private Placement
-
Lakeland Financial Reports Annual Net Income of $93.8 Million and 9% Annualized Average Loan Growth
-
Asia Broadband Announces Imminent Launch of New Proprietary and Upgraded AABB Wallet and Important User Advisory
-
Ocular Therapeutix™ Announces FDA Agreement to Amend Special Protocol Assessment (SPA) for Pivotal Clinical Trial of AXPAXLI™ in Wet AMD
-
Gaming and Leisure Properties, Inc. Schedules Fourth Quarter 2023 Earnings Release and Conference Call
-
Star Equity Holdings Announces $5.9 Million Sale-Leaseback Transaction
-
SS Innovations Partners with India’s Leading Medical Equipment Supplier, Medikabazaar
-
NV5 Acquires CHW Professional Consultants, Strengthening Florida Infrastructure Design and Survey Services
-
Maris-Tech Receives New Order for approximately $590,000 for an AI-based HLS and Defense Surveillance Application
-
Bionano Announces Publication of a Study that Applied OGM to Discovery of Structural Variants Driving Drug Resistance and Sensitivity in Cancer
-
Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference
-
BlockQuarry Corp. Issues Shareholder Letter, Noting Key Milestones and Corporate Goals
-
Kronos Bio Implements New Leadership Structure to Drive Pipeline Advancement
-
eFFECTOR Therapeutics Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
-
Super League Aligns Team to Super Serve Rapidly Expanding Roster of Partners Committing Sizable Budgets to the 3D Web
-
SILVERFISH ANNOUNCES NAME AND SYMBOL CHANGE
